acrolein

Acrolein (CH2=CH-CHO) is an unsaturated aldehyde produced as a byproduct when cyclophosphamide and ifosfamide are metabolized by hepatic cytochrome P450 enzymes. While the primary cytotoxic metabolite (phosphoramide mustard) exerts the desired antineoplastic/immunosuppressive alkylating effect, acrolein is excreted renally and accumulates in the bladder, where it causes direct epithelial damage, leading to hemorrhagic cystitis—manifesting as dysuria, hematuria, and increased risk of bladder fibrosis or secondary malignancy with chronic exposure. This toxicity is dose-limiting for ifosfamide and cyclophosphamide therapy. Prophylaxis includes: (1) Mesna (2-mercaptoethane sulfonate), which contains a free thiol group that binds and inactivates acrolein in the urinary tract, and (2) aggressive IV hydration with frequent voiding to dilute urinary acrolein concentration and reduce bladder mucosal contact time. Acrolein is also found in cigarette smoke and burnt/overheated cooking oils, contributing to respiratory irritation and oxidative stress in those contexts. Understanding this pathway is high-yield for USMLE questions linking cyclophosphamide/ifosfamide use to hemorrhagic cystitis and the mechanism/rationale for mesna co-administration.